[ABSTRAK Latar Belakang : Continous ambulatory peritoneal dialysis (CAPD) telah menjadialternatif selain hemodialisis untuk pengobatan penyakit ginjal tahap akhir. Fibrosisperitoneum merupakan penyebab utama terjadinya kerusakan membran peritoneum.Mekanisme fibrosis peritoneum belum diketahui secara pasti, namun ditengaraitransforming growth factor ? β (TGF ?β) berhubungan erat terhadap terjadinya fibrosisperitoneum.Tujuan : Tujuan penelitian ini adalah untuk mengetahui pengaruh kombinasi ACEinhibitor (ACEI) dan calcium channel Blocker (CCB) terhadap penurunan ekspresi TGF? β dan fibrosis peritoneum tikus jantan yang telah dilakukan CAPD.Metode Penelitian : Penelitian eksperimental, post test only control group design. Tigapuluh tikus Dawley spraque dibagi menjadi lima kelompok yaitu kelompok kontrol(kelompok 1) dan kelompok perlakuan dengan pemberian masing-masing cairan CAPD4,25% (kelompok2) lisinopril 1,44 mg oral dan CAPD (kelompok 3) diltiazem CD 6,48mg oral dan CAPD (kelompok 4) lisinopril 1,44 mg dan diltiazem CD 6,48 mg oral danCAPD (kelompok 5). Setelah 4 minggu tikus dikorbankan dengan cara dislokasi cervicalkemudian diperiksa ekspresi TGF ? β dan terjadinya fibrosis pada peritoneum tikus,selanjutnya dibuat sediaan histopatologi dan diwarnai dengan hematoksilin eosin sertaimunohistokimia menggunakan antihuman TGF-ß.Hasil : Dua puluh peritoneum tikus berhasil diperiksa. Rerata skor TGF-β kelompokkontrol 1,8, kelompok CAPD 2, kelompok lisinopril dan CAPD 1,8, kelompok diltiazemCD dan CAPD 1,8, kelompok lisinopril dan diltiazem CD dan CAPD 1,7 (p=0,959).Rerata skor fibrosis peritoneum kelompok kontrol 1,1, kelompok CAPD 2,6, kelompoklisinopril dan CAPD 1,2, kelompok diltiazem CD dan CAPD 1,3, kelompok lisinopril dandiltiazem CD dan CAPD1,5 (p=0,268)Simpulan : Kombinasi lisinopril dan diltiazem mempunyai kecenderungan menurunkanekspresi TGF ? β lebih baik dibandingkan lisinopril maupun diltiazem yang diberikansecara terpisah tetapi tidak bermakna secara statistik. Kombinasi lisinopril dan diltiazemmempunyai kecenderungan mengurangi fibrosis peritoneum tetapi tidak bermakna secarastatistik dan tidak lebih baik dibandingkan lisinopril maupun diltiazem bila diberikansecara terpisah. ABSTRACT Background : Continuous ambulatory peritoneal dialysis (CAPD) has been analternative other than hemodialysis for end stage kidney disease treatment.Peritoneal fibrosis is the most serious cause of the damage in membraneperitoneum. Mechanism of fibrosis peritoneum is not exactly known yet,transforming growth factor ? β(TGF ? β) is closely related with the existence offibrosis peritoneum.Purposes : The purpose of this study is to evaluate the effect of combinationbetween ACE inhibitor (ACEI) dan Calcium channel blocker (CCB) in reducingexpression of TGF ? β and fibrosis peritoneum in a male rat treated with CAPD.Research Method : Experimental study, post test only control group design.Thirsty Dawley spraque rats are divided into five groups control group ( Group1), CAPD liquid 4,25% (group 2), lisinopril 1,44 mg oral and CAPD (group 3)diltiazem CD 6,48 mg oral and CAPD (group 4) lisinopril 1,44mg + diltiazem CD6,48 mg oral and CAPD (group 5). After 4 weeks, rats sacrificed. Expression ofTGF ? β and peritoneal fibrosis are conducted by histopatology with hematoxillineosinstaining and immunology with anti human-TGF-β.Result : Twenty peritoneal of rats can be examined. Mean score TGF-β controlgroup is 1,8, CAPD group is 2, lisinopril and CAPD group is 1,8,diltiazem CDand CAPD group is 1,8, lisinopril and diltiazem CD and CAPD group is 1,7(p=0,959) .Mean score peritoneal fibrosis control group is 1,1, CAPD group is2,6, lisinopril and CAPD group is 1,2, diltiazem CD and CAPD group is 1,3,lisinopril and diltiazem CD and CAPD group is 1,5 (p=0,268)Summary : Combination of lisinopril and diltiazem lower the expression of TGF? β and fibrosis peritoneum better than lisinopril or diltiazem but statistically notsignificant. Combination of lisinopril and diltiazem lower the peritoneal fibrosisbut statistically not significant and it doesn?t better than lisinopril or diltiazem.Key words: ACE inhibitor, calcium channel blocker, TGF-β, peritoneal fibrosis.;Background : Continuous ambulatory peritoneal dialysis (CAPD) has been analternative other than hemodialysis for end stage kidney disease treatment.Peritoneal fibrosis is the most serious cause of the damage in membraneperitoneum. Mechanism of fibrosis peritoneum is not exactly known yet,transforming growth factor ? β(TGF ? β) is closely related with the existence offibrosis peritoneum.Purposes : The purpose of this study is to evaluate the effect of combinationbetween ACE inhibitor (ACEI) dan Calcium channel blocker (CCB) in reducingexpression of TGF ? β and fibrosis peritoneum in a male rat treated with CAPD.Research Method : Experimental study, post test only control group design.Thirsty Dawley spraque rats are divided into five groups control group ( Group1), CAPD liquid 4,25% (group 2), lisinopril 1,44 mg oral and CAPD (group 3)diltiazem CD 6,48 mg oral and CAPD (group 4) lisinopril 1,44mg + diltiazem CD6,48 mg oral and CAPD (group 5). After 4 weeks, rats sacrificed. Expression ofTGF ? β and peritoneal fibrosis are conducted by histopatology with hematoxillineosinstaining and immunology with anti human-TGF-β.Result : Twenty peritoneal of rats can be examined. Mean score TGF-β controlgroup is 1,8, CAPD group is 2, lisinopril and CAPD group is 1,8,diltiazem CDand CAPD group is 1,8, lisinopril and diltiazem CD and CAPD group is 1,7(p=0,959) .Mean score peritoneal fibrosis control group is 1,1, CAPD group is2,6, lisinopril and CAPD group is 1,2, diltiazem CD and CAPD group is 1,3,lisinopril and diltiazem CD and CAPD group is 1,5 (p=0,268)Summary : Combination of lisinopril and diltiazem lower the expression of TGF? β and fibrosis peritoneum better than lisinopril or diltiazem but statistically notsignificant. Combination of lisinopril and diltiazem lower the peritoneal fibrosisbut statistically not significant and it doesn?t better than lisinopril or diltiazem.Key words: ACE inhibitor, calcium channel blocker, TGF-β, peritoneal fibrosis.;Background : Continuous ambulatory peritoneal dialysis (CAPD) has been analternative other than hemodialysis for end stage kidney disease treatment.Peritoneal fibrosis is the most serious cause of the damage in membraneperitoneum. Mechanism of fibrosis peritoneum is not exactly known yet,transforming growth factor ? β(TGF ? β) is closely related with the existence offibrosis peritoneum.Purposes : The purpose of this study is to evaluate the effect of combinationbetween ACE inhibitor (ACEI) dan Calcium channel blocker (CCB) in reducingexpression of TGF ? β and fibrosis peritoneum in a male rat treated with CAPD.Research Method : Experimental study, post test only control group design.Thirsty Dawley spraque rats are divided into five groups control group ( Group1), CAPD liquid 4,25% (group 2), lisinopril 1,44 mg oral and CAPD (group 3)diltiazem CD 6,48 mg oral and CAPD (group 4) lisinopril 1,44mg + diltiazem CD6,48 mg oral and CAPD (group 5). After 4 weeks, rats sacrificed. Expression ofTGF ? β and peritoneal fibrosis are conducted by histopatology with hematoxillineosinstaining and immunology with anti human-TGF-β.Result : Twenty peritoneal of rats can be examined. Mean score TGF-β controlgroup is 1,8, CAPD group is 2, lisinopril and CAPD group is 1,8,diltiazem CDand CAPD group is 1,8, lisinopril and diltiazem CD and CAPD group is 1,7(p=0,959) .Mean score peritoneal fibrosis control group is 1,1, CAPD group is2,6, lisinopril and CAPD group is 1,2, diltiazem CD and CAPD group is 1,3,lisinopril and diltiazem CD and CAPD group is 1,5 (p=0,268)Summary : Combination of lisinopril and diltiazem lower the expression of TGF? β and fibrosis peritoneum better than lisinopril or diltiazem but statistically notsignificant. Combination of lisinopril and diltiazem lower the peritoneal fibrosisbut statistically not significant and it doesn?t better than lisinopril or diltiazem.Key words: ACE inhibitor, calcium channel blocker, TGF-β, peritoneal fibrosis.;Background : Continuous ambulatory peritoneal dialysis (CAPD) has been analternative other than hemodialysis for end stage kidney disease treatment.Peritoneal fibrosis is the most serious cause of the damage in membraneperitoneum. Mechanism of fibrosis peritoneum is not exactly known yet,transforming growth factor ? β(TGF ? β) is closely related with the existence offibrosis peritoneum.Purposes : The purpose of this study is to evaluate the effect of combinationbetween ACE inhibitor (ACEI) dan Calcium channel blocker (CCB) in reducingexpression of TGF ? β and fibrosis peritoneum in a male rat treated with CAPD.Research Method : Experimental study, post test only control group design.Thirsty Dawley spraque rats are divided into five groups control group ( Group1), CAPD liquid 4,25% (group 2), lisinopril 1,44 mg oral and CAPD (group 3)diltiazem CD 6,48 mg oral and CAPD (group 4) lisinopril 1,44mg + diltiazem CD6,48 mg oral and CAPD (group 5). After 4 weeks, rats sacrificed. Expression ofTGF ? β and peritoneal fibrosis are conducted by histopatology with hematoxillineosinstaining and immunology with anti human-TGF-β.Result : Twenty peritoneal of rats can be examined. Mean score TGF-β controlgroup is 1,8, CAPD group is 2, lisinopril and CAPD group is 1,8,diltiazem CDand CAPD group is 1,8, lisinopril and diltiazem CD and CAPD group is 1,7(p=0,959) .Mean score peritoneal fibrosis control group is 1,1, CAPD group is2,6, lisinopril and CAPD group is 1,2, diltiazem CD and CAPD group is 1,3,lisinopril and diltiazem CD and CAPD group is 1,5 (p=0,268)Summary : Combination of lisinopril and diltiazem lower the expression of TGF? β and fibrosis peritoneum better than lisinopril or diltiazem but statistically notsignificant. Combination of lisinopril and diltiazem lower the peritoneal fibrosisbut statistically not significant and it doesn?t better than lisinopril or diltiazem.Key words: ACE inhibitor, calcium channel blocker, TGF-β, peritoneal fibrosis.;Background : Continuous ambulatory peritoneal dialysis (CAPD) has been analternative other than hemodialysis for end stage kidney disease treatment.Peritoneal fibrosis is the most serious cause of the damage in membraneperitoneum. Mechanism of fibrosis peritoneum is not exactly known yet,transforming growth factor ? β(TGF ? β) is closely related with the existence offibrosis peritoneum.Purposes : The purpose of this study is to evaluate the effect of combinationbetween ACE inhibitor (ACEI) dan Calcium channel blocker (CCB) in reducingexpression of TGF ? β and fibrosis peritoneum in a male rat treated with CAPD.Research Method : Experimental study, post test only control group design.Thirsty Dawley spraque rats are divided into five groups control group ( Group1), CAPD liquid 4,25% (group 2), lisinopril 1,44 mg oral and CAPD (group 3)diltiazem CD 6,48 mg oral and CAPD (group 4) lisinopril 1,44mg + diltiazem CD6,48 mg oral and CAPD (group 5). After 4 weeks, rats sacrificed. Expression ofTGF ? β and peritoneal fibrosis are conducted by histopatology with hematoxillineosinstaining and immunology with anti human-TGF-β.Result : Twenty peritoneal of rats can be examined. Mean score TGF-β controlgroup is 1,8, CAPD group is 2, lisinopril and CAPD group is 1,8,diltiazem CDand CAPD group is 1,8, lisinopril and diltiazem CD and CAPD group is 1,7(p=0,959) .Mean score peritoneal fibrosis control group is 1,1, CAPD group is2,6, lisinopril and CAPD group is 1,2, diltiazem CD and CAPD group is 1,3,lisinopril and diltiazem CD and CAPD group is 1,5 (p=0,268)Summary : Combination of lisinopril and diltiazem lower the expression of TGF? β and fibrosis peritoneum better than lisinopril or diltiazem but statistically notsignificant. Combination of lisinopril and diltiazem lower the peritoneal fibrosisbut statistically not significant and it doesn?t better than lisinopril or diltiazem.Key words: ACE inhibitor, calcium channel blocker, TGF-β, peritoneal fibrosis., Background : Continuous ambulatory peritoneal dialysis (CAPD) has been analternative other than hemodialysis for end stage kidney disease treatment.Peritoneal fibrosis is the most serious cause of the damage in membraneperitoneum. Mechanism of fibrosis peritoneum is not exactly known yet,transforming growth factor – β(TGF – β) is closely related with the existence offibrosis peritoneum.Purposes : The purpose of this study is to evaluate the effect of combinationbetween ACE inhibitor (ACEI) dan Calcium channel blocker (CCB) in reducingexpression of TGF – β and fibrosis peritoneum in a male rat treated with CAPD.Research Method : Experimental study, post test only control group design.Thirsty Dawley spraque rats are divided into five groups control group ( Group1), CAPD liquid 4,25% (group 2), lisinopril 1,44 mg oral and CAPD (group 3)diltiazem CD 6,48 mg oral and CAPD (group 4) lisinopril 1,44mg + diltiazem CD6,48 mg oral and CAPD (group 5). After 4 weeks, rats sacrificed. Expression ofTGF – β and peritoneal fibrosis are conducted by histopatology with hematoxillineosinstaining and immunology with anti human-TGF-β.Result : Twenty peritoneal of rats can be examined. Mean score TGF-β controlgroup is 1,8, CAPD group is 2, lisinopril and CAPD group is 1,8,diltiazem CDand CAPD group is 1,8, lisinopril and diltiazem CD and CAPD group is 1,7(p=0,959) .Mean score peritoneal fibrosis control group is 1,1, CAPD group is2,6, lisinopril and CAPD group is 1,2, diltiazem CD and CAPD group is 1,3,lisinopril and diltiazem CD and CAPD group is 1,5 (p=0,268)Summary : Combination of lisinopril and diltiazem lower the expression of TGF– β and fibrosis peritoneum better than lisinopril or diltiazem but statistically notsignificant. Combination of lisinopril and diltiazem lower the peritoneal fibrosisbut statistically not significant and it doesn’t better than lisinopril or diltiazem.Key words: ACE inhibitor, calcium channel blocker, TGF-β, peritoneal fibrosis.] |